Sign In
HealthTech
Heard of Axelia Solutions or Aarman Solutions? They may not ring a bell, but they are vital to the business of PharmEasy, India’s leading online pharmacy and healthcare platform.
The two companies operate the platform, including the mobile app and website. PharmEasy’s well-known parent, API Holdings Limited, does not perform this function.
Confused? That’s the complex structure of API Holdings, which filed papers for a Rs 6,250-crore IPO last month, becoming the youngest Indian unicorn to make the public-market move.
API has over two dozen subsidiaries, thanks to a string of acquisitions it has made to build out the business in a heavily regulated market. Aarman and Axelia, however, do not figure among the subsidiaries. API has a shade below 20% stake in Aarman, which owns Axelia.
PharmEasy is run in this complicated manner because it has to comply with the wide-ranging rules governing foreign direct investment. India does not allow FDI in inventory-based models; outside money is permitted in only marketplace models.
Already a subscriber? Sign In
Be the smartest person in the room. Choose the plan that works for you and join our exclusive subscriber community.
Premium Articles
4 articles every week
Archives
>3 years of archives
Org. Chart
1 every week
Newsletter
4 every week
Gifting Credits
5 premium articles every month
Session
3 screens concurrently
₹3,999
Subscribe Now
Have a coupon code?
Join our community of 100,000+ top executives, VCs, entrepreneurs, and brightest student minds
Blume Ventures
The CapTable brings a refreshing set of insights for us at the Blume team, highlighting stories that bring together the underlying business and founders with that of investors' journeys with these startups. It's an important perspective that very few bring to startup ecosystem enthusiasts.
Convinced that The Captable stories and insights
will give you the edge?
Convinced that The Captable stories
and insights will give you the edge?
Subscribe Now
Sign Up Now
